Pioglitazone improves lipid profiles in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease

By Al-Gayyar Mohammed M. H.   Shams Mohamed E. E.   Barakat Enaase A. M. E.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 3, 2012-03 ,pp. : 297-303

Informa Healthcare

Access to resources Recommend Favorite

Beyond Low-Density Lipoprotein: Addressing the Atherogenic Lipid Triad in Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Nesto Richard W.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 379-387

Adis International

Access to resources Recommend Favorite

Pioglitazone improves HAART-induced metabolic syndrome

By  

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Risk Profiles in Type 2 Diabetes (Metabolic Syndrome): Integration of IL-10 Polymorphisms and Laboratory Parameters to Identify Vascular Damages Related Complications

By  

Current Pharmaceutical Design, Vol. 16, Iss. 7, 2010-03 ,pp. : 898-903

Bentham Science Publishers

Access to resources Recommend Favorite